TC Biopharm (Holdings) Plc
TCBPY
$0.28
$0.000.00%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 1.68M | 3.36M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 1.68M | 3.36M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | 1.68M | 3.36M |
| SG&A Expenses | 8.22M | 8.68M | 8.67M | 8.72M | 8.73M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 50.40K | 167.50K | 186.10K | 186.10K | 186.10K |
| Total Operating Expenses | 15.23M | 17.25M | 17.97M | 18.02M | 18.00M |
| Operating Income | -15.23M | -17.25M | -17.97M | -16.34M | -14.64M |
| Income Before Tax | -15.33M | -11.82M | -8.73M | -6.26M | -3.71M |
| Income Tax Expenses | -761.30K | -1.00M | -1.35M | -1.69M | -2.04M |
| Earnings from Continuing Operations | -14.57 | -10.82 | -7.38 | -4.56 | -1.68 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.57M | -10.82M | -7.38M | -4.56M | -1.68M |
| EBIT | -15.23M | -17.25M | -17.97M | -16.34M | -14.64M |
| EBITDA | -14.55M | -16.53M | -17.18M | -15.52M | -13.79M |
| EPS Basic | -402.30K | -- | -- | -- | -- |
| Normalized Basic EPS | -66.21 | -- | -- | -- | -- |
| EPS Diluted | -402.30K | -- | -- | -- | -- |
| Normalized Diluted EPS | -66.21 | -- | -- | -- | -- |
| Average Basic Shares Outstanding | 24.90K | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | 0.00 | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |